Intra-arterial bone marrow mononuclear cells in ischemic stroke: A pilot clinical trial

Stroke

Volumn 43, Issue 8, 2012, Pages 2242-2244

  Moniche, Francisco ^a   Gonzalez, Alejandro ^a   Gonzalez Marcos, Jose Ramon ^a   Carmona, Magdalena ^b   Piñero, Pilar ^a   Espigado, Ildefonso ^b   Garcia Solis, David ^a   Cayuela, Aurelio ^a   Montaner, Joan ^c   Boada, Cristina ^c   Rosell, Anna ^c   Jimenez, Maria Dolores ^a   Mayol, Antonio ^a   Gil Peralta, Alberto ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b Departments of Radiology   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

cell transplantation; cerebral infarct; stem cells

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NERVE GROWTH FACTOR BETA SUBUNIT;

ARTICLE; AUTOLOGOUS BONE MARROW MONONUCLEAR CELL TRANSPLANTATION; AUTOTRANSPLANTATION; BARTHEL INDEX; BLOOD SAMPLING; BONE MARROW TRANSPLANTATION; BRAIN ISCHEMIA; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; FEASIBILITY STUDY; FOCAL EPILEPSY; FOLLOW UP; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; MONONUCLEAR CELL; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANKIN SCALE; RECURRENT DISEASE; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; BONE MARROW TRANSPLANTATION; BRAIN ISCHEMIA; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMODYNAMICS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; NEUROLOGIC EXAMINATION; PILOT PROJECTS; SAFETY; STROKE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864284648     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.659409     Document Type: Article

References (7)

1. Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol. 2009;8:491-500.
2. Savitz SI, Misra V, Kasam M, Juneja H, Cox CS Jr, Alderman S, et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol. 2011;70:59-69.
3. Battistella V, de Freitas GR, da Fonseca LM, Mercante D, Gutfilen B, Goldenberg RC, et al. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med. 2011;6:45-52.
4. Friedrich MA, Martins MP, Araújo MD, Klamt C, Vedolin L, Garicochea B, et al. Intra-arterial infusion of autologous bone-marrow mononuclear cells in patients with moderate to severe middle-cerebral-artery acute ischemic stroke. Cell Transplant. 2012;21(suppl):S13-21.
5. Komatsu K, Honmou O, Suzuki J, Houkin K, Hamada H, Kocsis JD. Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. Brain Res. 2010;1334:84-92.
6. Schwarting S, Litwak S, Hao W, Bähr M, Weise J, Neumann H. Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke. 2008;39:2867-2875.
7. Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology. 2002;59:514-523.